Triple versus dual antiplatelet therapy of cilostazol or sarpogrelate with aspirin and clopidogrel after percutaneous coronary intervention: a retrospective cohort study using Korean National Health Insurance Claim Database

被引：0
|
作者：
Noh, Yoojin [1 ]
Lee, Jimin [1 ]
Shin, Sooyoung [1 ]
Lee, Sukhyang [1 ]
机构：
[1] Ajou Univ, Coll Pharm, Suwon 441749, South Korea
来源：
PHARMACOTHERAPY | 2015年 / 35卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
344
引用
收藏
页码：E260 / E260
页数：1
相关论文
共 50 条
  • [31] Esomeprazole and rabeprazole did not reduce antiplatelet effects of aspirin/clopidogrel dual therapy in patients undergoing percutaneous coronary intervention: a prospective, randomized, case-control study
    Liu, Li-Peng
    Wang, Yan
    Si, Rui
    Yuan, Ming
    Cheng, Kang
    Guo, Wen-Yi
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (01) : 7 - 16
  • [32] Cilostazol Based Triple versus Potent P2y12 Blockers Based Dual Antiplatelet Therapy in Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
    Rha, Seung Woon
    Kim, Woohyeun
    Choi, Byoung Geol
    Choi, Se Yeon
    Cha, Jinah
    Park, Yoonjee
    Kang, Dong Oh
    Jang, Won-Young
    Choi, Jah Yeon
    Na, Jin Oh
    Choi, Cheol Ung
    Park, Chang Gyu
    Seo, Hong-Seog
    CIRCULATION, 2019, 140
  • [33] Efficacy and Safety of Concomitant Use of Rabeprazole during Dual-antiplatelet Therapy with Clopidogrel and Aspirin after Drug-eluting Stent Implantation: A Retrospective Cohort Study
    Yasu, Takeo
    Ikee, Ryota
    Miyasaka, Yoshiyuki
    Chubachi, Hideo
    Saito, Shigeru
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (12): : 1743 - 1750
  • [34] Long-term Outcomes of Clopidogrel Monotherapy versus Prolonged Dual Antiplatelet Therapy beyond 12 Months after Percutaneous Coronary Intervention in High-risk Patients
    Kim, Dong-Yeon
    Cho, Sung Woo
    Park, Kyu Tae
    Ahn, Jong-Hwa
    Park, Taek Kyu
    Jang, Yong Ho
    Choi, Ki Hong
    Lee, Joo Myung
    Yang, Jeong Hoon
    Song, Young Bin
    Choi, Jin-Ho
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Lee, Sang Hoon
    Hahn, Joo-Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (16) : e106
  • [35] Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention
    Woohyeun Kim
    Jin-Seok Kim
    Seung-Woon Rha
    Byoung Geol Choi
    Won Young Jang
    Dong Oh Kang
    Yoonjee Park
    Jah Yeon Choi
    Seung-Young Roh
    Jin Oh Na
    Cheol Ung Choi
    Eung Ju Kim
    Chang Gyu Park
    Hong Seog Seo
    Se Yeon Choi
    Jae Kyeong Byun
    Jinah Cha
    Dong Joo Oh
    Myung Ho Jeong
    Heart and Vessels, 2020, 35 : 1181 - 1192
  • [36] Cilostazol-based triple versus potent P2Y12 inhibitor-based dual antiplatelet therapy in patients with acute myocardial infarction undergoing percutaneous coronary intervention
    Kim, Woohyeun
    Kim, Jin-Seok
    Rha, Seung-Woon
    Choi, Byoung Geol
    Jang, Won Young
    Kang, Dong Oh
    Park, Yoonjee
    Choi, Jah Yeon
    Roh, Seung-Young
    Na, Jin Oh
    Choi, Cheol Ung
    Kim, Eung Ju
    Park, Chang Gyu
    Seo, Hong Seog
    Choi, Se Yeon
    Byun, Jae Kyeong
    Cha, Jinah
    Oh, Dong Joo
    Jeong, Myung Ho
    HEART AND VESSELS, 2020, 35 (09) : 1181 - 1192
  • [37] Comparison of the Effect of Age (< 75 Versus ≥75) on the Efficacy and Safety of Dual Therapy (Dabigatran plus Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin plus Aspirin plus Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial)
    ten Berg, Jurrien M.
    Steg, Philippe Gabriel
    Bhatt, Deepak L.
    Hohnloser, Stefan H.
    de Veer, Anne
    Nordaby, Matias
    Miede, Corinna
    Kimura, Takeshi
    Lip, Gregory Y. H.
    Oldgren, Jonas
    Cannon, Christopher P.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (05): : 735 - 743
  • [38] Comparison of 1-Year Outcomes of Triple (Aspirin plus Clopidogrel plus Cilostazol) Versus Dual Antiplatelet Therapy (Aspirin plus Clopidogrel plus Placebo) After Implantation of Second-Generation Drug-Eluting Stents into One or More Coronary Arteries: from the DECREASE-PCI Trial
    Lee, Cheol Hyun
    Lee, Jong-Young
    Park, Gyung-Min
    Lee, Seung-Whan
    Kim, Hyun-Sook
    Choi, Young Jin
    Nam, Chang-Wook
    Cho, Jang Hyun
    Shin, Won-Yong
    Bin Seo, Jae
    Choi, Si Wan
    Lee, Jae-Hwan
    Min, Pil-Ki
    Her, Sung-Ho
    Lee, Pil Hyung
    Ahn, Jung -Min
    Park, Duk-Woo
    Kang, Soo-Jin
    Kim, Young-Hak
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (04): : 423 - 429
  • [39] Utilization of Anticoagulant and Antiplatelet Agents Among Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - Retrospective Cohort Study Using a Nationwide Claims Database in Japan
    Ono, Fumiko
    Tanaka, Shiro
    Nakao, Yoko M.
    Kawakami, Koji
    CIRCULATION JOURNAL, 2018, 82 (02) : 361 - +
  • [40] Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial
    Jingen Li
    Jianqing Ju
    Zhuo Chen
    Jing Liu
    Fang Lu
    Rui Gao
    Hao Xu
    Trials, 19
12345